Howard Hurt
Family Medicine · Bay City, MINPI 1881668374
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,137 and has fallen 93.8% since, to $71 in 2023.
Across 138 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$236
- Johnson & Johnson$203
- Merck$131
- UCB, Inc.$120
- Otsuka America Pharmaceutical, Inc.$117
- Nestle Healthcare Nutrition Inc.$110
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,222100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 13 | $236 |
| Johnson & Johnson | 13 | $203 |
| Merck | 8 | $131 |
| UCB, Inc. | 8 | $120 |
| Otsuka America Pharmaceutical, Inc. | 7 | $117 |
| Nestle Healthcare Nutrition Inc. | 7 | $110 |
| Sanofi-aventis U.S. LLC | 6 | $107 |
| Amgen | 6 | $101 |
| AstraZeneca(2 entities) | 6 | $90 |
| Amarin Pharma, Inc. | 5 | $85 |
| Astellas Pharma US Inc | 5 | $77 |
| Pfizer | 5 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Boehringer Ingelheim | 4 | $62 |
| GSK | 4 | $55 |
| Lilly USA, LLC | 4 | $53 |
| Acadia Pharmaceuticals Inc | 3 | $48 |
| Biogen | 2 | $41 |
| Avanir Pharmaceuticals, Inc. | 3 | $41 |
| Bayer | 2 | $38 |
| Sunovion Pharmaceuticals Inc. | 2 | $37 |
| AbbVie | 2 | $37 |
| Novo Nordisk | 3 | $36 |
| Mylan Specialty L.p. | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Abbott | 1 | $23 |
| Surgalign Spine Technologies, Inc. | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Edwards Lifesciences | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Radius Health, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Medtronic | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$2,222 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 16 | $209 |
| Amlodipine Besylate | 12 | $103 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bay City
- James CampauBay City$32K
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.